Editorial: Aldosterone-renin ratios in the context of primary care

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 9, 2004, Pages 4219-4220

  Funder, John W ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; RENIN; SPIRONOLACTONE;

ALDOSTERONE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; EDITORIAL; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; BLOOD; NOTE; PREVALENCE; PRIMARY HEALTH CARE;

ALDOSTERONE; HUMANS; HYPERTENSION; PREVALENCE; PRIMARY HEALTH CARE; RENIN;

EID: 4544325693     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1397     Document Type: Editorial

References (9)

1. Olivieri O, Ciacciarelli A, Signorelli O, Pizzolo F, Guarini P, Pavan C, Corgnati A, Falcone S, Corrocher R, Micchi A, Cressoni C, Blengio C 2004 Aldosterone to renin ratio in a primary care setting: the Bussolengo study. J Clin Endocrinol Metab 89:4221-4226
2. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T 1981 A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Arch Intern Med 141:1589-1593
3. Gordon RD, Ziezak MD, Tunny TJ, Stowasser M, Klemm SA 1993 Evidence that primary aldosteronism may not be uncommon: twelve percent incidence among antihypertensive drug trial volunteers. Clin Exp Pharmacol Physiol 20:296-298
4. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC 1994 High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21:315-318
5. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM 1999 Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 353:40
6. Levy D, Rocha R, Funder JW 2004 Distinguishing the antihypertensive and electrolyte effects of eplerenone. J Clin Endocrinol Metab 89:2736-2740
7. Rocha R, Martin-Berger C, Yang P, Scherrar R, Delyani J, McMahon E 2002 Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Endocrinology 143:4828-4836
8. Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B, Kleiman J, Krause S, Burns D, Williams GH 2003 Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 108:1831-1838
9. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, Benjamin EJ, Levy D 2004 Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 351:33-41